Abstract

BackgroundBariatric surgery contributes to the improvement in glucose metabolism that may be related to a postoperative increase in serum bile acids (BAs). Three commonly used types of bariatric procedures, laparoscopic sleeve gastrectomy (LSG) (without creation of a bile loop), Roux-en-Y gastric bypass (RYGB), and omega-loop gastric bypass (OLGB) (with creation of shorter 100–150 cm and longer 200–280 cm bile loops, respectively), differ in their effects on glycemic control. The aim of the study was to compare the effects of various bariatric procedures on serum BA concentration and glucose homeostasis.MethodsSerum BAs in 26 obese patients were determined by liquid chromatography-mass spectrometry prior to bariatric surgery, as well as 4 days and 3 months thereafter.ResultsFour days after the surgery, serum concentrations of BAs in LSG and OLGB groups were similar as prior to the procedure, and a slight decrease in serum BAs was observed in the RYGB group. Serum BA level in the LSG group remained unchanged also at 3 months after the surgery, whereas a significant 0.5- and 3-fold increase in this parameter was noted in the RYGB and OLGB groups, respectively. Serum concentration of BAs correlated positively with the length of the bile loop (R = 0.47, p < 0.05).ConclusionThe evident improvement of glycemic control observed 3 months after OLGB might be associated with a postoperative increase in serum BAs, resulting from their better absorption from the longer bile loop. However, the changes in serum BAs probably had little or no impact on insulin sensitivity improvement at 4 days post-surgery.

Highlights

  • Obesity is a major public health problem worldwide; it is frequently associated with various comorbidities, such as diabetes mellitus, metabolic syndrome, lipid disorders, cholelithiasis, sleep apnea, nonalcoholic fatty liver disease, chronic kidney disease, cardiovascular diseases, and some malignancies [1,2,3,4]

  • The exact mechanism underlying the beneficial effect of bariatric surgeries on glucose metabolism is still not fully understood, some evidence points to potential involvement of bile acids (BAs) [7]

  • Four days after the surgery, serum concentrations of BAs in the laparoscopic sleeve gastrectomy (LSG) and omega-loop gastric bypass (OLGB) groups were similar as prior to the procedure, and a slight albeit significant decrease in serum BAs was observed in the Roux-en-Y gastric bypass (RYGB) group (Fig. 2)

Read more

Summary

Introduction

Obesity is a major public health problem worldwide; it is frequently associated with various comorbidities, such as diabetes mellitus, metabolic syndrome, lipid disorders, cholelithiasis, sleep apnea, nonalcoholic fatty liver disease, chronic kidney disease, cardiovascular diseases, and some malignancies [1,2,3,4]. The most commonly used bariatric procedures include Roux-en-Y gastric bypass (RYGB), omega-loop gastric bypass (OLGB), and laparoscopic sleeve gastrectomy (LSG). All these procedures result in a weight loss and in the resolution of hyperglycemia, insulin resistance, and T2DM, all observed within hours or days after the surgery, well before the reduction of body weight [5, 6]. Three commonly used types of bariatric procedures, laparoscopic sleeve gastrectomy (LSG) (without creation of a bile loop), Roux-en-Y gastric bypass (RYGB), and omega-loop gastric bypass (OLGB) (with creation of shorter 100–150 cm and longer 200–280 cm bile loops, respectively), differ in their effects on glycemic control. The aim of the study was to compare the effects of various bariatric procedures on serum BA concentration and glucose homeostasis

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call